HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 63 filers reported holding HARPOON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 156 | -97.3% | 0.00% | – |
| Q1 2022 | $29,000 | -34.1% | 5,775 | 0.0% | 0.00% | – |
| Q4 2021 | $44,000 | -4.3% | 5,775 | -0.6% | 0.00% | – |
| Q3 2021 | $46,000 | -80.8% | 5,809 | -66.5% | 0.00% | – |
| Q2 2021 | $240,000 | +9.1% | 17,331 | +64.8% | 0.00% | – |
| Q1 2021 | $220,000 | +25.7% | 10,519 | 0.0% | 0.00% | – |
| Q4 2020 | $175,000 | -2.2% | 10,519 | 0.0% | 0.00% | – |
| Q3 2020 | $179,000 | +2.3% | 10,519 | 0.0% | 0.00% | – |
| Q2 2020 | $175,000 | +207.0% | 10,519 | +113.8% | 0.00% | – |
| Q1 2020 | $57,000 | -21.9% | 4,919 | 0.0% | 0.00% | – |
| Q4 2019 | $73,000 | +9.0% | 4,919 | 0.0% | 0.00% | – |
| Q3 2019 | $67,000 | +857.1% | 4,919 | +883.8% | 0.00% | – |
| Q2 2019 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |